2024年7月25日 · ZYVOX® (linezolid) injection, for intravenous use ... 1.1 Nosocomial Pneumonia - ZYVOX is indicated for the treatment of nosocomial pneumonia caused by Staphylococcus …

2010年12月22日 · ZYVOX formulations are indicated in the treatment of the following infections caused by susceptible strains of the designated microorganisms (see PRECAUTIONS, …

ZYVOX - U.S. Medical Information Page - patient information, ways to contact Pfizer Medical & other resources for Healthcare professionals: ZYVOX U.S. Physician Prescribing Information

2016年2月9日 · ZYVOX is an oxazolidinone-class antibacterial indicated in adults and children for the treatment of the following infections caused by susceptible Gram-positive bacteria: …

NDC 0009-5137 Zyvox Linezolid. Zyvox is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Pharmacia & Upjohn Company Llc. …

ZYVOX formulations and other antibacterial drugs, ZYVOX should be used only to treat 11 or prevent infections that are proven or strongly suspected to be caused by bacteria.

The sodium concentration of linezolid (Zyvox) ready-to-use solution for infusion is 0.38 mg/mL or 1.7 mEq in a 100-mL bag, 3.3 mEq in a 200-mL bag, and 5 mEq in a 300-mL bag. 3183

2024年12月17日 · Pfizer has Zyvox 200 mg/100 mL bags are also on back order and the company estimates a release date of December 2027. Sandoz has linezolid 600 mg/300 mL …

0009-4992-02 : Linezolid ( Zyvox ) Additionally : You can get information about “0009-4992-02” NDC code in HTML | TXT | PDF | XML formats.

Zyvox is used in the treatment of Methicillin-Resistant Staphylococcus Aureus Infection; Bacterial Infection; Nosocomial Pneumonia; Skin and Structure Infection; Pneumonia and belongs to the …